Summary
This narrative review examines the anti-inflammatory potential of dietary polyphenols in the clinical management of inflammatory bowel disease. The authors synthesise evidence on mechanisms by which polyphenolic compounds—commonly found in plant-based foods—may modulate the dysregulated immune responses and intestinal inflammation characteristic of IBD. The review likely positions polyphenol-rich dietary strategies as a potential adjunctive or preventive approach to conventional IBD pharmacotherapy, though clinical translation remains limited.
Regional applicability
Findings are relevant to UK dietary guidelines and clinical practice for IBD management, particularly in supporting whole-food, plant-rich dietary recommendations. However, evidence strength and regulatory status of polyphenol extracts or supplements in the NHS context would require assessment against NICE and British Society of Gastroenterology guidance.
Key measures
Inflammatory biomarkers (e.g. cytokines, TNF-α, IL-6), intestinal barrier function markers, polyphenol bioavailability, disease activity scores in IBD
Outcomes reported
The study likely reviewed evidence on how polyphenolic compounds modulate inflammatory pathways relevant to inflammatory bowel disease (IBD) pathogenesis and symptom management. Outcomes probably encompassed inflammatory markers, mechanistic pathways, and potential therapeutic applications of polyphenol-rich interventions.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.